CARA Therapeutics, Inc. Stock, NASDAQ:CARA
4 Stamford Plaza, 107 Elm Street, Stamford, Connecticut 06902
United States of America
Number of Employees: 67
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.